Stay updated on Tivozanib vs Sorafenib in Refractory RCC Clinical Trial

Sign up to get notified when there's something new on the Tivozanib vs Sorafenib in Refractory RCC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Tivozanib vs Sorafenib in Refractory RCC Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Napoli, Italy, 80131 was replaced with Naples, Italy, 80131 in the locations section.
    Difference
    0.0%
    Check dated 2026-03-27T12:28:19.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    Revision label updated to v3.5.0, replacing the previous v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-20T03:30:22.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    Revision tag updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-12T21:09:45.000Z thumbnail image
  4. Check
    27 days ago
    No Change Detected
  5. Check
    49 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added to replace Revision: v3.4.1 on the page. This appears to be a minor site version update not affecting study details.
    Difference
    0.0%
    Check dated 2026-02-12T02:06:38.000Z thumbnail image
  6. Check
    56 days ago
    Change Detected
    Summary
    Footer revision updated from v3.4.0 to v3.4.1. The change is a minor deployment note and does not modify study content, navigation, or displayed data. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-04T22:47:36.000Z thumbnail image
  7. Check
    63 days ago
    Change Detected
    Summary
    This update adds a glossary toggle and a revision label (v3.4.0), and adjusts QC-related headers and FEAR Act terminology.
    Difference
    0.1%
    Check dated 2026-01-28T20:22:26.000Z thumbnail image

Stay in the know with updates to Tivozanib vs Sorafenib in Refractory RCC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Tivozanib vs Sorafenib in Refractory RCC Clinical Trial page.